These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3378293)

  • 21. [The effect of exogenous peroxidase on the intensity of luminol-dependent macrophage chemiluminescence].
    Tokmakov AA; Vasil'ev VIu
    Tsitologiia; 1990; 32(9):888-92. PubMed ID: 2291242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro inhibition of macrophage spreading by antigens and lymphokines: correlation with the footpad test and kinetics of inhibition.
    Mazuran R; Silobrcić V
    Ann Inst Pasteur Immunol; 1987; 138(2):201-11. PubMed ID: 3606840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of macrophages for killing of rickettsiae: analysis of macrophage effector function after rickettsial inoculation of inbred mouse strains.
    Nacy CA; Meltzer MS; Leonard EJ; Stevenson MM; Skamene E
    Adv Exp Med Biol; 1983; 162():335-53. PubMed ID: 6408905
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the mechanism of macrophage aggregation induced by lymphokines.
    Badenoch-Jones P; Rouveix B; Turk JL
    Immunology; 1979 Jun; 37(2):361-6. PubMed ID: 223977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication.
    Byrne GI; Murray HW
    Adv Exp Med Biol; 1983; 162():361-4. PubMed ID: 6869092
    [No Abstract]   [Full Text] [Related]  

  • 26. Enzyme production and secretion by lymphokine-activated macrophages.
    Pantalone R; Page RC
    J Reticuloendothel Soc; 1977 May; 21(5):343-57. PubMed ID: 196081
    [No Abstract]   [Full Text] [Related]  

  • 27. Characteristics of IL-3 derived and IL-3 dependent lymphocyte cell lines.
    Hapel AJ; Lee JC; Greenberger J; Ihle JN
    Adv Exp Med Biol; 1982; 149():719-24. PubMed ID: 6216774
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A; Fischer M; Roehm N; Zipori D
    J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of bacterial lipopolysaccharide and lymphokine in the regulation of macrophage activation: correlates between secretion of plasminogen activator and tumor lysis.
    Jones CM; Taramelli D; Clouse CA; Goldfarb RG
    Immunobiology; 1984 May; 166(4-5):410-27. PubMed ID: 6541192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of increase in macrophage Ia expression on subsequent immune response in vivo.
    Koga T; Mitsuyama M; Watanabe Y; Yamada A; Yoshikai Y; Nomoto K
    J Clin Lab Immunol; 1986 May; 20(1):29-35. PubMed ID: 3090269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages.
    Wu-Hsieh B; Howard DH
    J Immunol; 1984 May; 132(5):2593-7. PubMed ID: 6371138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid quantitation of changes in macrophage volume induced by lymphokine in vitro.
    Poulter LW; Turk JL
    Clin Exp Immunol; 1975 Jan; 19(1):193-9. PubMed ID: 1106913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition.
    Gilbreath MJ; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1986 Sep; 137(5):1681-7. PubMed ID: 3745916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
    Nacy CA; Meltzer MS; Fortier AH
    J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
    Taffet SM; Pace JL; Russell SW
    J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphokines facilitate maturation of oligodendrocytes in vitro.
    Suzumura A; Silberberg DH
    Brain Res; 1989 Feb; 480(1-2):51-7. PubMed ID: 2713667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages.
    Bout DT; Joseph M; David JR; Capron AR
    J Immunol; 1981 Jul; 127(1):1-5. PubMed ID: 7240738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphokine enhances oxygen-independent activity against intracellular pathogens.
    Murray HW; Byrne GI; Rothermel CD; Cartelli DM
    J Exp Med; 1983 Jul; 158(1):234-9. PubMed ID: 6864162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.